195 related articles for article (PubMed ID: 31603676)
1. Structural Basis of HIV-1 Inhibition by Nucleotide-Competing Reverse Transcriptase Inhibitor INDOPY-1.
Ruiz FX; Hoang A; Das K; Arnold E
J Med Chem; 2019 Nov; 62(21):9996-10002. PubMed ID: 31603676
[TBL] [Abstract][Full Text] [Related]
2. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.
Jochmans D; Deval J; Kesteleyn B; Van Marck H; Bettens E; De Baere I; Dehertogh P; Ivens T; Van Ginderen M; Van Schoubroeck B; Ehteshami M; Wigerinck P; Götte M; Hertogs K
J Virol; 2006 Dec; 80(24):12283-92. PubMed ID: 17020946
[TBL] [Abstract][Full Text] [Related]
3. Formation of a quaternary complex of HIV-1 reverse transcriptase with a nucleotide-competing inhibitor and its ATP enhancer.
Ehteshami M; Nijhuis M; Bernatchez JA; Ablenas CJ; McCormick S; de Jong D; Jochmans D; Götte M
J Biol Chem; 2013 Jun; 288(24):17336-46. PubMed ID: 23598281
[TBL] [Abstract][Full Text] [Related]
4. Impact of primer-induced conformational dynamics of HIV-1 reverse transcriptase on polymerase translocation and inhibition.
Auger A; Beilhartz GL; Zhu S; Cauchon E; Falgueyret JP; Grobler JA; Ehteshami M; Götte M; Melnyk RA
J Biol Chem; 2011 Aug; 286(34):29575-83. PubMed ID: 21737446
[TBL] [Abstract][Full Text] [Related]
5. Unconventional plasticity of HIV-1 reverse transcriptase: how inhibitors could open a connection "gate" between allosteric and catalytic sites.
Bellucci L; Angeli L; Tafi A; Radi M; Botta M
J Chem Inf Model; 2013 Dec; 53(12):3117-22. PubMed ID: 24256065
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of HIV-1 reverse transcriptase bound to a non-nucleoside inhibitor with a novel mechanism of action.
Freisz S; Bec G; Radi M; Wolff P; Crespan E; Angeli L; Dumas P; Maga G; Botta M; Ennifar E
Angew Chem Int Ed Engl; 2010 Mar; 49(10):1805-8. PubMed ID: 20135654
[No Abstract] [Full Text] [Related]
7. Exploring the dNTP -binding site of HIV-1 reverse transcriptase for inhibitor design.
Gu W; Martinez S; Singh AK; Nguyen H; Rozenski J; Schols D; Herdewijn P; Das K; De Jonghe S
Eur J Med Chem; 2021 Dec; 225():113785. PubMed ID: 34425311
[TBL] [Abstract][Full Text] [Related]
8. Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors.
La Regina G; Coluccia A; Silvestri R
Antivir Chem Chemother; 2010 Aug; 20(6):213-37. PubMed ID: 20710063
[TBL] [Abstract][Full Text] [Related]
9. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.
Meleddu R; Distinto S; Corona A; Bianco G; Cannas V; Esposito F; Artese A; Alcaro S; Matyus P; Bogdan D; Cottiglia F; Tramontano E; Maccioni E
Eur J Med Chem; 2015 Mar; 93():452-60. PubMed ID: 25728026
[TBL] [Abstract][Full Text] [Related]
10. Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors".
Ehteshami M; Scarth BJ; Tchesnokov EP; Dash C; Le Grice SF; Hallenberger S; Jochmans D; Götte M
J Biol Chem; 2008 Oct; 283(44):29904-11. PubMed ID: 18728003
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.
Das K; Sarafianos SG; Clark AD; Boyer PL; Hughes SH; Arnold E
J Mol Biol; 2007 Jan; 365(1):77-89. PubMed ID: 17056061
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series.
Rajotte D; Tremblay S; Pelletier A; Salois P; Bourgon L; Coulombe R; Mason S; Lamorte L; Sturino CF; Bethell R
Antimicrob Agents Chemother; 2013 Jun; 57(6):2712-8. PubMed ID: 23545531
[TBL] [Abstract][Full Text] [Related]
13. Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.
Li A; Ouyang Y; Wang Z; Cao Y; Liu X; Ran L; Li C; Li L; Zhang L; Qiao K; Xu W; Huang Y; Zhang Z; Tian C; Liu Z; Jiang S; Shao Y; Du Y; Ma L; Wang X; Liu J
J Med Chem; 2013 May; 56(9):3593-608. PubMed ID: 23540737
[TBL] [Abstract][Full Text] [Related]
14. Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
Medina-Franco JL; Martínez-Mayorga K; Juárez-Gordiano C; Castillo R
ChemMedChem; 2007 Aug; 2(8):1141-7. PubMed ID: 17477343
[No Abstract] [Full Text] [Related]
15. Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine.
Singh AK; De Wijngaert B; Bijnens M; Uyttersprot K; Nguyen H; Martinez SE; Schols D; Herdewijn P; Pannecouque C; Arnold E; Das K
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2203660119. PubMed ID: 35858448
[TBL] [Abstract][Full Text] [Related]
16. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
[TBL] [Abstract][Full Text] [Related]
17. New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
Famiglini V; La Regina G; Coluccia A; Pelliccia S; Brancale A; Maga G; Crespan E; Badia R; Clotet B; Esté JA; Cirilli R; Novellino E; Silvestri R
Eur J Med Chem; 2014 Jun; 80():101-11. PubMed ID: 24769348
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.
Li D; Zhan P; De Clercq E; Liu X
J Med Chem; 2012 Apr; 55(8):3595-613. PubMed ID: 22268494
[No Abstract] [Full Text] [Related]
19. Chemometrical identification of mutations in HIV-1 reverse transcriptase conferring resistance or enhanced sensitivity to arylsulfonylbenzonitriles.
Rodríguez-Barrios F; Gago F
J Am Chem Soc; 2004 Mar; 126(9):2718-9. PubMed ID: 14995186
[TBL] [Abstract][Full Text] [Related]
20. Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase.
Nakamura A; Tamura N; Yasutake Y
Acta Crystallogr F Struct Biol Commun; 2015 Nov; 71(Pt 11):1384-90. PubMed ID: 26527265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
